Fazekas F - Search Results

1

Vascular dementia and Alzheimer's disease - are we in a dead-end road?

Cavalieri M, Enzinger C, Petrovic K, Pluta-Fuerst A, Homayoon N, Schmidt H, Fazekas F, Schmidt R. Cavalieri M, et al. Among authors: fazekas f. Neurodegener Dis. 2010;7(1-3):122-6. doi: 10.1159/000285521. Epub 2010 Feb 18. Neurodegener Dis. 2010. PMID: 20173341 Review.

2

Evolution of white matter lesions.

Schmidt R, Schmidt H, Kapeller P, Lechner A, Fazekas F. Schmidt R, et al. Among authors: fazekas f. Cerebrovasc Dis. 2002;13 Suppl 2:16-20. doi: 10.1159/000049145. Cerebrovasc Dis. 2002. PMID: 11901238 Review.

3

CT and MRI rating of white matter lesions.

Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R. Fazekas F, et al. Cerebrovasc Dis. 2002;13 Suppl 2:31-6. doi: 10.1159/000049147. Cerebrovasc Dis. 2002. PMID: 11901240 Review.

4

The natural course of MRI white matter hyperintensities.

Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R, Fazekas F. Schmidt R, et al. Among authors: fazekas f. J Neurol Sci. 2002 Nov 15;203-204:253-7. doi: 10.1016/s0022-510x(02)00300-3. J Neurol Sci. 2002. PMID: 12417393 Review.

5

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

6

Method for quantitative imaging of the macromolecular 1H fraction in tissues.

Ropele S, Seifert T, Enzinger C, Fazekas F. Ropele S, et al. Among authors: fazekas f. Magn Reson Med. 2003 May;49(5):864-71. doi: 10.1002/mrm.10427. Magn Reson Med. 2003. PMID: 12704769 Free article.

7

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F; Austrian Stroke Prevention Study. Schmidt R, et al. Among authors: fazekas f. Lancet. 2003 Jun 14;361(9374):2046-8. doi: 10.1016/s0140-6736(03)13616-1. Lancet. 2003. PMID: 12814718

8

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews PM, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Ann Neurol. 2004 Apr;55(4):563-9. doi: 10.1002/ana.20027. Ann Neurol. 2004. PMID: 15048896

9

Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.

Enzinger C, Strasser-Fuchs S, Ropele S, Kapeller P, Kleinert R, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Mult Scler. 2005 Apr;11(2):135-9. doi: 10.1191/1352458505ms1145oa. Mult Scler. 2005. PMID: 15794384

10

MTI of white matter hyperintensities.

Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, Schmidt R. Fazekas F, et al. Brain. 2005 Dec;128(Pt 12):2926-32. doi: 10.1093/brain/awh567. Epub 2005 Jun 15. Brain. 2005. PMID: 15958507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters